{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:42:53Z","timestamp":1789684973338,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>Over 50% of patients are already taking blood pressure\u2013lowering therapy on hospital admission for acute stroke. An individual patient data meta-analysis from randomized controlled trials was undertaken to determine the effect of continuation versus temporarily stopping preexisting antihypertensive medication in acute stroke. Key databases were searched for trials against the following inclusion criteria: randomized design; stroke onset \u226448 hours; investigating the effect of continuation versus stopping prestroke antihypertensive medication; and follow-up of \u22652 weeks. Two randomized controlled trials were identified and included in this meta-analysis of individual patient data from 2860 patients with \u226448 hours of acute stroke. Risk of bias in each study was low. In adjusted logistic regression and multiple regression analyses (using random effects), we found no significant association between continuation of prestroke antihypertensive therapy (versus stopping) and risk of death or dependency at final follow-up: odds ratio 0.96 (95% confidence interval, 0.80\u20131.14). No significant associations were found between continuation (versus stopping) of therapy and secondary outcomes at final follow-up. Analyses for death and dependency in prespecified subgroups revealed no significant associations with continuation versus temporarily stopping therapy, with the exception of patients randomized \u226412 hours, in whom a difference favoring stopping treatment met statistical significance. We found no significant benefit with continuation of antihypertensive treatment in the acute stroke period. Therefore, there is no urgency to administer preexisting antihypertensive therapy in the first few hours or days after stroke, unless indicated for other comorbid conditions.<\/jats:p>","DOI":"10.1161\/hypertensionaha.116.07982","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T02:05:41Z","timestamp":1488852341000},"page":"933-941","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Continuing or Temporarily Stopping Prestroke Antihypertensive Medication in Acute Stroke"],"prefix":"10.1161","volume":"69","author":[{"given":"Lisa J.","family":"Woodhouse","sequence":"first","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Manning","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Potter","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Wardlaw","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy R.","family":"Lees","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Bath","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thompson G.","family":"Robinson","sequence":"additional","affiliation":[{"name":"From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (L.J.W., N.S., P.M.B.); University Hospitals of Leicester NHS Trust, United Kingdom (L.M.); Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norfolk, United Kingdom (J.F.P.); Department of Internal Medicine, Oslo University Hospital, Norway (E.B.); Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.W.); Institute of..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2006.07.008"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.548602"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2001.00831.x"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000014509.11540.66"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.596163"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214609"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61121-1"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15490-1"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282543"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60104-9"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318284056a"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.181486"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.183689"},{"key":"e_1_3_4_15_2","volume-title":"Stroke: Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack. NICE Guidelines","author":"NICE","year":"2008","unstructured":"NICE. Stroke: Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack. NICE Guidelines. London: Royal College of Physicians (UK); 2008."},{"key":"e_1_3_4_16_2","article-title":"Interventions for deliberately altering blood pressure in acute stroke (review).","volume":"10","author":"Bath PMW","year":"2014","unstructured":"Bath PMW, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke (review). Cochrane Database Syst Rev. 2014;10.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000092488.40085.15"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70163-0"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.02.003"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000108159"},{"key":"e_1_3_4_22_2","article-title":"Efficacy of nitricoxide in Stroke (ENOS) trial.","author":"Bath PMW","year":"2007","unstructured":"Bath PMW. Efficacy of nitricoxide in Stroke (ENOS) trial. Summary of protocol (version 1.5). 2007 http:\/\/www.enos.ac.uk\/enossummaryv15.htm. Accessed October 21, 2013.","journal-title":"Summary of protocol (version 1.5)"},{"key":"e_1_3_4_23_2","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].","author":"Higgins JPT","year":"2011","unstructured":"Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at www.handbook.cochrane.org. Accessed February 22, 2017.","journal-title":"The Cochrane Collaboration"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318284056a"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70198-4"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.594168"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.001301"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000075777.18006.89"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6624.737"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70031-6"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70018-3"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60235-8"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.116.07982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:44:24Z","timestamp":1730292264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.116.07982"}},"subtitle":["An Individual Patient Data Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.116.07982"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.116.07982","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"2016-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}